Related Experiment Video
Updated: Jan 18, 2026

Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT
Published on: January 7, 2018
Hypoglycaemia During Oral Glucose Tolerance Test in Pregnancy and Feto-Maternal Outcomes: A Systematic Review and
Deep Dutta1, Manoj Kumar2, Radhika Jindal3
1Department of Endocrinology, Center for Endocrinology Diabetes Arthritis and Rheumatism (CEDAR) Superspeciality Healthcare, Dwarka, New Delhi, India.
Abstract:
The significance of hypoglycaemia during oral glucose tolerance tests (OGTT) in pregnancy is uncertain. This systematic review and meta-analysis (SRM) evaluated if hypoglycaemia during OGTT predicts feto-maternal outcomes. Electronic databases were searched for studies in pregnancy where an OGTT at 24-28 weeks was done and feto-maternal outcomes were documented. Hypoglycaemia during OGTT (reactive hypoglycaemia) was defined as blood glucose < 90 mg/dl or less than the fasting-glucose value. Primary outcomes were the occurrence of small-for-gestational-age (SGA) and neonatal intensive-care unit (NICU) admission. Secondary outcomes were birthweight, macrosomia, large-for-gestational-age (LGA), gestational age at delivery (GA), 5-minute Apgar score (5AS), caesarean section (CS), and pregnancy-induced hypertension (PIH). Association of hypoglycaemia with pre-pregnancy maternal weight, maternal weight gain during pregnancy, and maternal age was noted. PRISMA guidelines were followed, and the preestablished protocol was registered on PROSPERO (CRD42025644556). From initially screened 448 articles, data from 13 articles involving 30,462 women were analysed. Compared to normoglycemia, hypoglycaemia during OGTT was associated with significantly higher SGA [OR1.81;95%CI1.31-2.50; P = .0003], higher NICU admission [OR 1.44; 95% CI 1.17-1.76; P < .001; I2 = 0%], lower birthweight [MD-68.38g; 95%CI -126.25- -10.52; P = .020], lower macrosomia [OR 0.60;95%CI 0.42-0.86;P < .005], higher 5AS <8 [OR2.53;95%CI1.37-4.68; P = .003], lower CS [OR 0.82;95%CI0.75-0.90; P < .0001], lower maternal pre-pregnancy weight [MD -4.90 kg; 95%CI 9.17-0.62; P = .02; I 2 = 75%] and higher gestational-hypertension [OR 1.31; 95%CI 1.03 -1.66;P = .030]. The rates of SGA, LGA, 5AS <8, and maternal age were similar in women with hypoglycaemia and gestational diabetes. Hypoglycaemia during OGTT is associated with gestational hypertension, lower birthweight, increased SGA, higher NICU admission, and higher 5AS <8. Lower maternal pre-pregnancy weight was a predictor of hypoglycaemia during OGTT.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Hypoglycemia and Glucagon
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Oral Hypoglycemic Agents: Biguanides and Glitazones
Oral Hypoglycemic Agents: Glinides
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
Acarbose and miglitol are...

